Both methods demand specialized equipment, pharmaceutical-grade reagents, and rigorous contamination control
doi: 10.1016/j.chom.2013.04.010 102 KotEBezkorovainyA
By contrast, a recent clinical trial by Eli Lilly tracked nearly 400 subjects who switched from shots to Foundayo, and found that on average, they maintained most of their weight loss after 52 weeks
Summary Keywords intermittent fasting, precision medicine, anti-obesity pharmacotherapy, cardiovascular disease, genetics, GLP-1, GIP Citation Eliopoulos AG, Gkouskou KK, Tsioufis K and Sanoudou D (2025) A perspective on intermittent fasting and cardiovascular risk in the era of obesity pharmacotherapy
[1] [4] Glutathione may interact with certain medications and therapies